Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now being tested in humans.

A groundbreaking human trial of ER-100, a cellular reprogramming therapy, has begun, testing whether damaged eye cells can be ...

Today, more people are living past 100 than ever before — even though the maximum human lifespan hasn't moved past 115 years.

First human gets experimental gene shot to rewind ageing cells in the eye Life Biosciences has dosed its first patient with ER-100, a treatment that uses partial cellular reprogramming to target ...

Test time has arrived: the first person has been treated in a highly anticipated gene-therapy trial that aims to coax aged cells to take on a younger identity. The clinical trial is testing an ...

Blindness itself might become, at least in certain cases, partially reversible. This potential future stems from one of the ...

Pleased to announce the first patient has been dosed in our Phase 1 clinical trial, evaluating our lead candidate for optic ...

Aging, at its most fundamental level, is a molecular process. Chemical marks on the genome shift and lose fidelity over time, ...

Life Biosciences says it just dosed its first patient in an FDA-approved clinical trial to reverse age-related blindness.

A Boston biotech company has administered what researchers are describing as the first human dose of a cellular rejuvenation drug, a milestone in the effort to treat age-related disease at the ...

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. A first-of-its-kind shot that promises to reverse aging was just injected into a human body. It's a ...

Scientists at MD Anderson Cancer Center have revealed how ATRX mutations restructure chromatin and activate oncogenic ...